Sight Sciences, Inc.

NASDAQ:SGHT

2.8 (USD) • At close February 4, 2025
Bedrijfsnaam Sight Sciences, Inc.
Symbool SGHT
Munteenheid USD
Prijs 2.8
Beurswaarde 142,112,880
Dividendpercentage 0%
52-weken bereik 2.675 - 8.45
Industrie Medical Devices
Sector Healthcare
CEO Mr. Paul Badawi
Website https://www.sightsciences.com

An error occurred while fetching data.

Over Sight Sciences, Inc.

Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System,

Vergelijkbare Aandelen

Protagonist Therapeutics, Inc. logo

Protagonist Therapeutics, Inc.

PTGX

37.58 USD

Akoya Biosciences, Inc. logo

Akoya Biosciences, Inc.

AKYA

2.62 USD

ADMA Biologics, Inc. logo

ADMA Biologics, Inc.

ADMA

16.9 USD

AxoGen, Inc. logo

AxoGen, Inc.

AXGN

18.08 USD

Tarsus Pharmaceuticals, Inc. logo

Tarsus Pharmaceuticals, Inc.

TARS

54.5 USD

OrganiGram Holdings Inc. logo

OrganiGram Holdings Inc.

OGI

1.51 USD

Repare Therapeutics Inc. logo

Repare Therapeutics Inc.

RPTX

1.19 USD

Incannex Healthcare Limited logo

Incannex Healthcare Limited

IXHL

0.84 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)